EUVIMEDEUVIMED entdecken
Open Access

Novel In-line Filter Reduces ABO Circulating Antibodies in Whole Blood

Gregory C Wetmore iD, Ryan C Chae, Lindsey J Wattley, Rebecca Schuster, Bernadin Joseph, Michael D Goodman, Jose A Cancelas, Maryann Gruda, Timothy A Pritts iD

Military Medicine · 01.08.2026 · 191 (Supplement_1) · 293-301

DOI: 10.1093/milmed/usag076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, online erschienen am 06.08.2026. Verfasst von Gregory C Wetmore und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0558, United States. Hauptthemen laut MEDLINE: ABO Blood-Group System, Filtration, Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Air Force, NIH HHS, Ruth L. Kirschstein National Research Service Award Institutional Training.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Low titer O whole blood (LTOWB) is the preferred blood product for resuscitation after hemorrhage in civilian and military trauma. The low titer requirement minimizes the risk of hemolytic transfusion reactions caused by donor ABO antibodies. However, up to 25% of otherwise eligible donors are excluded because of high antibody titers. A novel in-line filter has been developed to bind and remove donor antibodies from whole blood during infusion. We evaluated the efficacy of this filter across multiple infusion methods and assessed its effects on whole blood composition and coagulation potential. Materials and Methods This study was reviewed and approved as non-human research by the Institutional Review Board. Low-titer O whole blood (LTOWB) units were obtained from our regional blood bank. In the first experimental series, LTOWB units were split into unmodified native whole blood (n = 5) and spiked whole blood (n = 5) to which murine anti-human anti-A and -B antibodies were added to achieve elevated titers before simulated infusion using 3 commercially available methods (gravity, rapid manual, and automated rapid normothermic) and samples were collected after infusion both with and without the in-line filter. In a second series, unmodified native whole blood units were evaluated by cell count, flow cytometry, viscoelastic thromboelastometry, and platelet (PLT) aggregometry with and without in-line filtration. Comparisons were made using Mann-Whitney and paired t-tests.

Results

Use of the in-line filter significantly reduced anti-A and anti-B titers across all infusion methods, with the greatest reduction seen after gravity infusion. Gravity filtration was also associated with the most pronounced changes in whole blood characteristics, including reductions in white blood cell count, PLT count, hematocrit, and hemoglobin. Viscoelastic testing revealed modest alterations in maximum clot firmness, alpha angle, and PLT contribution to clot. Multiplate aggregometry demonstrated reductions in area under the curve on both arachidonic acid and adenosine diphosphate agonist assays.

Conclusions

The novel in-line filter effectively reduces circulating anti-A and -B antibody titers in whole blood, though the extent of reduction varies by infusion method. Filtration induces mild changes in hematologic and coagulation parameters, but overall, filtered whole blood maintains the critical attributes for hemostatic resuscitation. Further studies are warranted to optimize filtration rates for maximal antibody clearance and to assess the impact of filtration rates for maximal antibody clearance. This approach may expand the LTOWB donor pool by enabling safe use of high-titer anti-A/anti-B donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ABO Blood-Group SystemFiltrationAntibodiesHumans

Substanzen

ABO Blood-Group SystemAntibodies

Autor:innen und Institutionen

  • Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0558, United States.
  • Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH 45219, United States.
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, United States.
  • CytoSorbents Corporation, Princeton, NJ 08540, United States.

ORCID-Profile: Gregory C Wetmore, Timothy A Pritts

Förderung

  • U.S. Air Force
  • NIH HHS
  • Ruth L. Kirschstein National Research Service Award Institutional Training
  • National Institutes of Health

Zitieren

APA

Wetmore, G. C., Chae, R. C., Wattley, L. J., Schuster, R., Joseph, B., Goodman, M. D., Cancelas, J. A., Gruda, M., & Pritts, T. A. (2026). Novel In-line Filter Reduces ABO Circulating Antibodies in Whole Blood. Military Medicine, 191(Supplement_1), 293-301. https://doi.org/10.1093/milmed/usag076

Vancouver

Wetmore GC, Chae RC, Wattley LJ, Schuster R, Joseph B, Goodman MD, et al. Novel In-line Filter Reduces ABO Circulating Antibodies in Whole Blood. Military Medicine. 2026;191(Supplement_1):293-301. doi:10.1093/milmed/usag076

BibTeX
@article{Wetmore2026,
  author = {Wetmore, Gregory C and Chae, Ryan C and Wattley, Lindsey J and Schuster, Rebecca and Joseph, Bernadin and Goodman, Michael D and Cancelas, Jose A and Gruda, Maryann and Pritts, Timothy A},
  title = {Novel In-line Filter Reduces ABO Circulating Antibodies in Whole Blood},
  journal = {Military Medicine},
  year = {2026},
  volume = {191},
  number = {Supplement_1},
  pages = {293--301},
  doi = {10.1093/milmed/usag076}
}
Kostenlos starten →